Howard University Center for Sickle Cell Disease — Washington D.C., District of Columbia

Howard University Center for Sickle Cell Disease is a clinical research site located in Washington D.C., District of Columbia, United States 20001.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Howard University Center for Sickle Cell Disease has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Anemia, Sickle Cell, Sickle Cell Disease.

Sponsors: Biossil Inc., Cyclerion Therapeutics, University of Pittsburgh.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Howard University Center for Sickle Cell Disease?

Howard University Center for Sickle Cell Disease has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Howard University Center for Sickle Cell Disease conducted?

Howard University Center for Sickle Cell Disease has 3 clinical trials on record, with 1 currently active. Their work covers Anemia, Sickle Cell, Sickle Cell Disease.

Is Howard University Center for Sickle Cell Disease accredited by Crixeo Health?

Howard University Center for Sickle Cell Disease has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Howard University Center for Sickle Cell Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.